Edric Engert BS, MBA

Mr. Engert founded Abraxeolus Consulting in 2005 and has over 20 years experience in the healthcare sector. Prior to Abraxeolus, Mr. Engert worked as the head of the Biosimilars Unit for Teva as well as Global Head of Portfolio and In-licensing for Teva’s Generics business in North Wales, PA, Vice President of Strategy and Global Head of Portfolio Management and In-licensing at Sandoz in both Vienna, Austria and Princeton, NJ, and Engagement Manager at McKinsey & Company in Washington, DC. He holds an MBA from The Wharton School of Business and a BS in Mathematics from The Massachusetts Institute of Technology.